|
Cecil B. Pickett, Ph.D., is senior vice president and president, Schering-Plough Research Institute, the pharmaceutical research arm of Schering-Plough Corporation, a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 30,000 people around the world. This company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com. Dr. Pickett is responsible for all aspects of Schering-Plough Research Institute.
Dr. Pickett was appointed to his present position in March 2002. He joined Schering-Plough Research Institute in 1993, and most recently was executive vice president, discovery research, responsible for the planning, management and oversight of Schering-Plough's new drug discovery programs across all therapeutic areas, and for coordinating those programs with other research and commercial components in the Company.
Dr. Pickett came to Schering-Plough Research Institute from Merck Research Laboratories, Montreal, Canada, and West Point, Pa., where he served as senior vice president, basic research. During his 15-year employ at Merck & Co., Dr. Pickett held various positions of increasing responsibility, including research fellow, biochemical regulation; associate director, department of molecular pharmacology and biochemistry; director, department of molecular pharmacology and biochemistry; executive director of research at the Merck Frosst Center for Therapeutic Research, Montreal; and vice president of the Center.
Dr. Pickett received his B.S. degree in biology from California State University, Hayward, Calif., and his Ph.D. degree in cell biology from the University of California, Los Angeles (UCLA).
Dr. Pickett has been published extensively in leading research journals and has been a frequent speaker at scientific symposia and conferences. He has received several major academic awards, appointments and fellowships and serves on a number of scientific committees and editorial boards of medical journals and research organizations. His awards and honors include the UCLA Alumni Association Award for Scholarly Achievement and Academic Distinction (1976); Macy Scholar, Marine Biological Laboratories, Woods Hole, Mass. (1978); first Robert A. Scala Award and Lectureship in Toxicology of Rutgers University and the University of Medicine and Dentistry of New Jersey (1993); Distinguished Lecturer, Jonsson Comprehensive Cancer Center, UCLA (1995); and the CIIT Centers for Health Research Founders' Award (2001).
Dr. Pickett served as a member of the U.S. Food and Drug Administration (FDA) Science Board, the Advisory Committee to the Director of the National Institutes of Health and The National Cancer Policy Board of the Institute of Medicine. He was elected to the Institute of Medicine of the National Academy of Sciences in 1993 and is also a member of The American Society for Cell Biology, American Society of Biochemistry & Molecular Biology, American Association for Cancer Research, and American Association for the Advancement of Science. He is a member of the volunteer Board of Directors of the New Jersey Performing Arts Center. | 